Major Alterations of Phosphatidylcholine and Lysophosphotidylcholine Lipids in the Substantia Nigra Using an Early Stage Model of Parkinson's Disease.
about
Metabolomic biomarkers as strong correlates of Parkinson disease progressionLipid profiling of parkin-mutant human skin fibroblasts.Essential Dietary Bioactive Lipids in Neuroinflammatory Diseases.Monte Carlo cross-validation analysis screens pathway cross-talk associated with Parkinson's disease.Biomarker Research in Parkinson's Disease Using Metabolite Profiling.Plasma disturbance of phospholipid metabolism in major depressive disorder by integration of proteomics and metabolomics.
P2860
Major Alterations of Phosphatidylcholine and Lysophosphotidylcholine Lipids in the Substantia Nigra Using an Early Stage Model of Parkinson's Disease.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Major Alterations of Phosphati ...... Model of Parkinson's Disease.
@ast
Major Alterations of Phosphati ...... Model of Parkinson's Disease.
@en
type
label
Major Alterations of Phosphati ...... Model of Parkinson's Disease.
@ast
Major Alterations of Phosphati ...... Model of Parkinson's Disease.
@en
prefLabel
Major Alterations of Phosphati ...... Model of Parkinson's Disease.
@ast
Major Alterations of Phosphati ...... Model of Parkinson's Disease.
@en
P2093
P2860
P356
P1476
Major Alterations of Phosphati ...... Model of Parkinson's Disease.
@en
P2093
Catherine A Smith
Jeffrey Smith
Kyle Farmer
Shawn Hayley
P2860
P304
18865-18877
P356
10.3390/IJMS160818865
P407
P577
2015-08-12T00:00:00Z